LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

Search

Atara Biotherapeutics Inc

Closed

SectorHealthcare

7.97 -0.5

Overview

Share price change

24h

Current

Min

7.86

Max

8.07

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+111.97% upside

Dividends

By Dow Jones

Next Earnings

8 Aug 2025

News Sentiment

By Acuity

50%

50%

154 / 380 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

Atara Biotherapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

7 Mar 2025, 21:54 UTC

Earnings

Atara Biotherapeutics to Cut Half of Workforce Amid Restructuring

16 Jan 2025, 16:17 UTC

Major Market Movers

Atara Shares Sink After FDA Stalls Cancer Treatment

16 Jan 2025, 14:31 UTC

Major Market Movers

FDA Rejects Atara's Request to Bring Blood Cancer Treatment to Market

Peer Comparison

Price change

Atara Biotherapeutics Inc Forecast

Price Target

By TipRanks

111.97% upside

12 Months Forecast

Average 17 USD  111.97%

High 17 USD

Low 17 USD

Based on 1 Wall Street analysts offering 12 month price targets forAtara Biotherapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

7.245 / 7.64Support & Resistance

Short Term

Weak Bearish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

154 / 380 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Above average

Financials

$